A function in apoptosis other than transactivation inherent in the NH2-terminal domain of p53

International Journal of Cancer

Volumn 71, Issue 5, 1997, Pages 858-866

  Theis, Stefan ^a   Atz, Judith ^a   Mueller Lantzsch, Nikolaus ^a   Roemer, Klaus ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; ETOPOSIDE; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSACTIVATION; TUMOR CELL LINE; TUMOR SUPPRESSION GENE;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; DNA; DNA FRAGMENTATION; MICE; MICE, TRANSGENIC; MUTATION; PEPTIDE FRAGMENTS; PROMOTER REGIONS (GENETICS); TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030949069     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970529)71:5<858::AID-IJC26>3.0.CO;2-2     Document Type: Article

References (22)

1. 1/S when p53 is transactivation competent and GVM when it is transactivation detective. EMBO J., 14, 4994-5005 (1995).
2. ATTARDI, L.D., LOWE, S.W., BRUGAROLAS, J. and JACKS, T., Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis. EMBO J., 15, 3693-3701 (1996).
3. CAELLES, C., HELMBERG, A. and KARIN, M., p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature (Lond.), 370, 220-223 (1994).
4. CANMAN, C., GILMER, T.M., COUTTS, S.B. and KASTAN, M.B., Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Development, 9, 600-611 (1995).
5. 1 checkpoint control. Cell, 82, 675-684 (1995).
6. GOGA, A., LIU, X., HAMBUCH, T.M., SENECHAL, K., MAJOR, E., BERK, A.J., WITTE, O.N. and SAWYERS, C.L., p53 dependent growth suppression by the c-Abl nuclear tyrosine kinase. Oncogene, 11, 791-799 (1995).
7. GOTTLIEB, T.M. and OREN, M., p53 in srowth control and neoplasia. Biochim. biophys. Acta, 1287, 77-102 (1996).
8. HAN, J., SABBATINI, P., PEREZ, D., RAO, L., MODHA, D. and WHITE, E., The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein. Genes Development, 10, 461-477 (1996).
9. HAUPT, Y. BARAK, Y. and OREN, M., Cell type-specific inhibition of p53-mediated apoptosis by mdm2. EMBO J., 15, 1596-1606 (1996).
10. HAUPT, Y. ROWAN, S., SHAULIAN, E., VOUSDEN, K.H. and OREN, M., Induction of apoptosis in HeLa cells by transactivation-deticient p53. Genes Development, 9, 2170-2183 (1995).
11. LEW, D., BRADY, H., KLAUSLNG, K., YAGINUMA, K., THEILL, L.E., STAUBER, C., KARIN, M. and MELLON, P.L., GHF-1 promoter-targeted immortalization of a somatotropic progenitor cell results in dwarfism in transgenic mice. Genes Development, 7, 683-693 (1993).
12. LIN, J., CHEN, J., ELENBAAS, B. and LEVINE, A.J., Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes Development, 8, 1235-1246 (1994).
13. LIU, X. and BERK, A.J., Reversal of in vitro p53 squelchina by both TFIIB and TFIID. Mol. cell. Biol., 15, 6474-6478 (1995).
14. LIU, X., MILLER, C.W., KOEFFLER, P.M. and BERK, A.J., The p53 activation domain binds the TATA box-binding polypeptide in holo-TFIID, and a neighboring p53 domain inhibits transcription. Mol. cell. Biol., 13, 3291-3300 (1993).
15. MAHESWARAN, S., ENGLERT, C., BENNETT, P., HEINRICH, G. and HABER, D.A., The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. Genes Development, 9, 2143-2156 (1995).
16. MIYASHITA, T. and REED, J.C., Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80, 293-299 (1995).
17. PIHTENPOL, J.A., TOKINO, T., THIAGALINGAM, S., EL-DEIRY, W.S., KlNZLER, K.W. and VOGELSTEIN, B., Sequence-specific translational activation is essential for growth suppression by p53. Proc. nat. Acad. Sci. (Wash.), 91, 1998-2002 (1994).
18. ROEMER, K. and MUELLER-LANTZSCH, N., p53 transactivation domain mutant Q22.S23 is impaired for the repression of promoters and mediation of apoptosis. Oncogene, 12, 2069-2079 (1996).
19. SABBATINI, P., LIN, J., LEVINE, AJ. and WHITE, E., Essential role for p53-mediated transcription in E1A-induced apoptosis. Genes Development, 9, 2184-2192 (1995).
20. SERRANO, M., LEE, H.-W., CHIN, L., CORDON-CARDO, C., BEACH, D. and DEPINHO, R.A., Role of the INK4a locus in tumor suppression and cell mortality. Cell. 85, 25-37 (1996).
21. SHEN, Y. and SHENK, T., Relief of p53-mediated transcriptional repression by adenovirus E1B 19-kDa protein or Bcl-2. Proc. nat. Acad. Sci. (Wash.), 91, 8940-8944 (1994).
22. THUT, C.J., CHEN, J.-L., KLEMM, R. and TJIAN, R., p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60. Science, 267, 100-104 (1995).